Shanghai Rice (002252.SZ) related directors and supervisors increased their holdings by a total of 7271,000 shares

Shanghai Laishi (002252.SZ) issued an announcement. The period from February 8, 024 to May 27, 2024...

Zhitong FinanceMay 28 07:14 ET

Shanghai Rice (002252.SZ) 2023 equity distribution: 0.3 yuan for every 10 shares

Shanghai Rice (002252.SZ) issued an announcement. The company's 2023 equity distribution plan is: With the company's current...

Zhitong FinanceMay 28 07:11 ET

Shanghai Laishi (002252.SZ): SR604, which is currently undergoing phase I clinical research, is a recombinant protein monoclonal antibody product produced using biosynthesis technology

Glonghui May 14 丨 Shanghai Rice (002252.SZ) held a performance briefing on May 13, 2024, to discuss “Does the company have synthetic organisms?” The company replied that SR604, which the company is currently carrying out phase I clinical research, is a recombinant protein monoclonal antibody product produced using biosynthesis technology.

Gelonghui FinanceMay 14 04:07 ET

Shanghai Laishi (002252.SZ): Guangxi Laishi will mainly produce human blood albumin, human immunoglobulin, and intravenous human immunoglobulin

Gelonghui, May 14, 丨 Shanghai Rice (002252.SZ) held a performance briefing on May 13, 2024. Regarding “When is Guangxi Laishi expected to enter the pulping stage and can produce several types of products, please introduce specific products?” The company replied that all work in Guangxi Laishi is being carried out normally in accordance with the plans and arrangements already disclosed. Guangxi Laishi will mainly produce human blood albumin, human immunoglobulin, and intravenous human immunoglobulin.

Gelonghui FinanceMay 14 04:05 ET

Shanghai Rice (002252.SZ): Net profit of 757 million yuan in the first quarter increased 5.32% year-on-year

On April 29, GLONGHUI (002252.SZ) released its first quarter report. Operating revenue was 2,056 billion yuan, down 0.33% year on year, net profit of 757 million yuan, up 5.32% year on year, after deducting 590 million yuan in non-net profit, down 16.64% year on year, with basic earnings of 0.114 yuan per share.

Gelonghui FinanceApr 29 08:46 ET

Shanghai Race (002252.SZ) reported 2023 annual results, with net profit of 1,779 billion yuan, a year-on-year decrease of 5.35%

Shanghai Rice (002252.SZ) released its 2023 annual report. The company achieved an operating income of 79 during the reporting period...

Zhitong FinanceApr 28 06:59 ET